![Eric van der Putten](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric van der Putten
Direttore/Membro del Consiglio presso Mimetas BV
Posizioni attive di Eric van der Putten
Società | Posizione | Inizio | Fine |
---|---|---|---|
Aglaia Management BV
![]() Aglaia Management BV Investment ManagersFinance Aglaia Management BV is an independent venture capital investment firm headquartered in Bilthoven, the Netherlands. In 2003, Aglaia was co-founded by Mark Krul and Karl Rothweiler. | Investitore di Private Equity | 01/09/2014 | - |
Mimetas BV
![]() Mimetas BV BiotechnologyHealth Technology Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Eric van der Putten
Precedenti posizioni note di Eric van der Putten
Società | Posizione | Inizio | Fine |
---|---|---|---|
Modra Pharmaceuticals BV
![]() Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Modra Pharmaceuticals BV designs and develops oral formulations of commonly used anti-cancer drugs. It is a clinical-stage company which develops series of oral formulations of existing IV anticancer drugs which reduce the side effects common to IV formulations, thereby improving patient convenience. The company was founded in June 2010 and is headquartered in Amsterdam, the Netherlands. | Direttore/Membro del Consiglio | 19/12/2018 | - |
Amministratore Delegato | 01/01/2016 | 19/12/2018 |
Statistiche
Distribuzione geografica
Paesi Bassi | 4 |
Posizioni
Director/Board Member | 2 |
Private Equity Investor | 1 |
Chief Executive Officer | 1 |
Settori
Health Technology | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Aglaia Management BV
![]() Aglaia Management BV Investment ManagersFinance Aglaia Management BV is an independent venture capital investment firm headquartered in Bilthoven, the Netherlands. In 2003, Aglaia was co-founded by Mark Krul and Karl Rothweiler. | Finance |
Mimetas BV
![]() Mimetas BV BiotechnologyHealth Technology Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands. | Health Technology |
Modra Pharmaceuticals BV
![]() Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Modra Pharmaceuticals BV designs and develops oral formulations of commonly used anti-cancer drugs. It is a clinical-stage company which develops series of oral formulations of existing IV anticancer drugs which reduce the side effects common to IV formulations, thereby improving patient convenience. The company was founded in June 2010 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Eric van der Putten
- Esperienza